The field of oncology has fundamentally shifted from a one-size-fits-all approach to highly personalized, targeted therapies that attack cancer cells based on their unique molecular vulnerabilities. This revolution, however, is impossible without a crucial partner: companion diagnostics (CDx). These specialized tests are the gatekeepers of precision medicine, providing the essential information...